查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402582

早產和胎膜早破測試市場：依產品類型、依測試類型、依最終用戶、依地區

Preterm Birth and PROM Testing Market, By Product Type, By Test Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

早產和胎膜早破檢測的市場規模預計將從 2023 年的 17 億美元增加到 2030 年的 26 億美元，預測期內複合年成長率為 6.3%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 17億美元
實際資料 2018-2021 預測期 2023-2030
預測期複合年成長率 6.30% 2030年市場規模預測 26億美元
圖 1. 2023 年依地區分類的早產和胎膜早破測試的全球市場佔有率(%)
早產和胎膜早破測試市場-IMG1

早產，又稱早產，是一個重大的全球健康問題。早產是指妊娠37週前出生。根據世界衛生組織 (WHO) 統計，每年約有 1500 萬嬰兒早產，約佔全球新生兒的十分之一。早產可導致多種健康併發症，是新生兒死亡和發病的主要原因之一。

PROM測試代表產前胎膜破裂，是用於評估早產風險的重要診斷工具。有助於在分娩開始前及早發現胎膜破裂。透過檢測羊水的存在，胎膜早破測試可以幫助醫療保健專業人員在管理和照顧有早產風險的孕婦方面做出明智的決定。

市場動態：

早產和胎膜早破檢測市場主要是由全球早產發生率上升所推動的。產婦年齡、多胎妊娠、產前護理不足、感染疾病和社會經濟因素等因素導致早產增加。 PROM 檢測在識別早產風險方面發揮著重要作用，使醫療保健專業人員能夠及時採取干涉措施並改善新生兒結果。

然而，也存在阻礙市場成長的因素。其中包括胎膜早破檢測套組價格高昂、發展中地區醫療機構的使用機會有限以及孕婦和醫護人員對早產和胎膜早破檢測的認知較低。

同時，由於 PROM 測試的技術進步、對即時檢測的日益關注以及對個人化醫療的需求不斷成長，市場上存在著巨大的商機。市場參與者正在投資研發工作，以開發創新的 PROM檢測套組，以提高準確性、易用性和成本效益。

總體而言，由於早產意識的提高、胎膜早破檢測方法的進步以及早期檢測和早期療育以改善新生兒結局的需求，早產和胎膜早破檢測市場正在經歷顯著成長。市場相關人員正在採取策略來擴大產品系列、與主要相關人員合作並探索未開發的市場潛力。

本研究的主要特點

  • 本報告對全球早產和胎膜早破檢測市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年成長率。
  • 本報告還強調了各個區隔市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
  • 本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 本報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球早產和胎膜早破測試市場的主要企業。
  • 該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球早產和胎膜早破測試市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球早產和胎膜早破測試市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品類型啟動/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第 4 章 早產和胎膜早破測試市場 –冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 2018-2030 年早產及胎膜早破測試市場（依產品類型）

  • 套件和試劑
  • 用具
  • 消耗品

第6章 2018-2030 年早產及胎膜早破測試市場（依測試類型）

  • 骨盆腔檢查
  • 超音波
  • 子宮監測
  • 生物標記測試
  • 其他

第 7 章 2018-2030 年早產和胎膜早破測試市場（依最終用戶分類）

  • 醫院
  • 診斷實驗室
  • 門診
  • 研究中心
  • 其他

第 8 章 2018-2030 年早產及胎膜早破檢驗市場（依地區）

  • 北美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • Abbott Laboratories
  • Biosynex
  • Qiagen NV
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Insight Pharmaceuticals LLC
  • Creative Diagnostics

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6403

The preterm birth and PROM testing market size is expected to reach US$ 2.6 Bn by 2030, from US$ 1.7 Bn in 2023, at a CAGR of 6.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.7 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.30% 2030 Value Projection: US$ 2.6 Bn
Figure 1. Global Preterm Birth and PROM Testing Market Share (%), by Region, 2023
Preterm Birth and PROM Testing Market - IMG1

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preterm birth and PROM testing market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

  • By Product Type
    • Kits and Reagents
    • Instruments
    • Consumables
  • By Test Type
    • Pelvic exam
    • Ultrasound
    • Uterine monitoring
    • Biomarker testing
    • Others
  • By End User
    • Hospitals
    • Diagnostics laboratories
    • Outpatient clinics
    • Research centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Preterm Birth and PROM Testing Market
    • Abbott Laboratories
    • Biosynex
    • Qiagen Sciences LLC
    • Clinical Innovations, LLC
    • Sera Prognostics
    • Hologic, Inc.
    • IQ Products
    • NX Prenatal, Inc.
    • Promega Corporation
    • Medical predictive Technologies Inc.
    • Creative Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Preterm Birth And PROM Testing Market, By Product Type
    • Preterm Birth And PROM Testing Market, By Test Type
    • Preterm Birth And PROM Testing Market, By End User
    • Preterm Birth And PROM Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of preterm births
    • High costs of prenatal diagnostic tests
    • Significant untapped potential in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Preterm Birth and PROM Testing Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kits and Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

6. Preterm Birth and PROM Testing Market, By Test Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pelvic exam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Uterine monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Biomarker testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Preterm Birth and PROM Testing Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Diagnostics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Outpatient clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Preterm Birth and PROM Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosynex
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clinical Innovations, LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sera Prognostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IQ Products
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NX Prenatal, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Insight Pharmaceuticals LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Creative Diagnostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us